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Bovine cytotoxic T-cell clones specific for cells infected with the
protozoan parasite Theileria parva: Parasite strain specificity
and class I major histocompatibility complex restriction
(East Coast fever/cell-mediated immunity/immunoprecipitation/cattle)
BRUNO M. GODDEERIS, W. IVAN MORRISON, ALAN J. TEALE, ALBERT BENSAID*, AND CYNTHIA L. BALDWIN
International Laboratory for Research on Animal Diseases, P.O. Box 30709, Nairobi, Kenya
Communicated by Don W. Fawcett, March 17, 1986
ABSTRACT We present information on the specificity of
three bovine cytotoxic T-cell clones reactive with lymphoblasts
infected with the protozoan parasite Theileriaparva. The clones
were derived from peripheral blood mononuclear cells of an
animal immunized with T. parva (Muguga stock), after five
stimulations in vitro with an autologous parasitized cell line.
The three clones belonged to the BoT8+ subset ofT cells, which
is similar to the human CD8' T-cell subset. On the basis of
analysis on a panel of infected target cells originating from
cattle of different major histocompatibility complex (MHC)
phenotypes, killing by all three clones was found to be
restricted to targets bearing the class IMHC specificity KN1O4,
which is defined by alloantiserum KNA104 and monoclonal
antibody IL-A4. This class IMHC restriction was confirmed by
blocking of target cell lysis with these antibodies and mono-
clonal antibody w6/32, which reacts with a nonpolymorphic
determinant on bovine class IMHC molecules. The three clones
were parasite strain specific, in that they did not kill cells of the
appropriate MHC type infected with T. parva (Marikebuni
stock). These findings, taken together with previous observa-
tions that immunization of cattle with T. parva (Muguga) does
not provide protection against challenge with T. parva
(Marikebuni), suggest that the cytotoxic T cells recognize a cell
surface antigen that may be important in induction ofimmunity
to the parasite.
The tick-borne protozoan parasite Theileria parva causes an
acute, usually fatal, disease of cattle, known as East Coast
fever, which results in major economic losses throughout
East and Central Africa. The parasite enters bovine lympho-
cytes, which subsequently undergo blast transformation and
multiplication. Parasite and host cell divide synchronously
(1), resulting in rapid clonal expansion of the parasitized cells
and high levels of parasitosis in the lymphoid tissues of
infected cattle.
Cattle that recover spontaneously from infection or are
immunized by infection and treatment regimes are immune to
challenge with the homologous stock of the parasite but may
be susceptible to challenge with heterologous stocks (2-5).
The immunological basis of this parasite strain heterogeneity
is poorly understood. Evidence from studies of cattle under-
going immunization suggests that cell-mediated immune
responses to parasitized lymphoblasts are important in im-
munity (reviewed in ref. 6). Genetically restricted cytotoxic
cells specific for parasitized targets are detected transiently
in the peripheral blood of immune cattle (6-8). Preliminary
observations have indicated that these cytotoxic cell popu-
lations have a degree of parasite strain specificity (9).
Further analysis ofthe specificity ofthe cytotoxic response
and its role in immunity has been hampered by difficulties in
generating effector cells in vitro with specificity similar to
that of those arising in vivo. Cytotoxic cells have been
induced in autologous Theileria mixed leukocyte cultures
(MLCs), in which peripheral blood mononuclear cells (PBM)
are stimulated by autologous infected cells, but invariably
they contained a major component that was not specific for
parasitized targets (10-12). By repeated stimulation in autol-
ogous Theileria MLCs, we have obtained populations of T
cells that are highly enriched for Theileria-specific cytotoxic
cells. We report here findings on the MHC restriction and
parasite strain specificity ofthree Theileria-specific cytotoxic
T-cell clones derived from one such culture.
MATERIALS AND METHODS
Cattle. Donors ofPBM were Boran (Bos indicus), Friesian,
Ayrshire, or Hereford (Bos taurus) female or castrated male
cattle, ranging from 6 to 48 months of age. The animal from
which cytotoxic T cells were derived was a 3-year-old Boran
steer (B641). All animals were clinically normal and were
serologically negative for antibodies to Theileria parva
schizonts at the outset of the experiments (13).
Typing for Major Histocompatibility Complex (MHC) An-
tigens. Class I MHC allelic products of the bovine lympho-
cyte antigen (BoLA) A locus (14) were defined in a
microlymphocytotoxicity test using a panel of alloantisera
(15). Animal B641 had the BoLA-A phenotype w10/KN18. In
all cases, PBM and their derivative cell lines had the same
MHC phenotype.
Cell Lines. Lymphoblastoid cell lines infected with T.
parva were established from PBM or cloned T cells by
infection in vitro with sporozoites from tick salivary glands
(16). The sporozoites used were from the Muguga and
Marikebuni stocks of T. parva, which are known to differ on
the basis of cross-protection (5). Some of the infected cell
lines were cloned in limiting-dilution cultures. Culture me-
dium consisted of RPMI 1640 medium containing 10% heat-
inactivated fetal bovine serum (GIBCO, Uxbridge, U.K.), 2
mM L-glutamine, gentamycin at 50 pug/ml, and 50 ,uM
2-mercaptoethanol. Confirmation that cell lines were infected
with particular parasite stocks was made by typing the
intracellular schizont with parasite strain-specific monoclon-
al antibodies (mAbs) (17).
To obtain uninfected lymphoblasts for use as target cells in
cytotoxicity assays, PBM were stimulated once by conca-
navalin A (Con A) and then maintained by regular addition of
20% T-cell growth factor (TCGF). The TCGF consisted of
conditioned medium from bovine PBM stimulated by Con A
Abbreviations: MHC, major histocompatibility complex; MLC,
mixed leukocyte culture; BoLA, bovine lymphocyte antigen; PBM,
peripheral blood mononuclear cells; mAb, monoclonal antibody;
TCGF, T-cell growth factor.
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(18). One day before use, the cells were given 20% TCGF
containing 0.1 M methyl a-D-mannoside (Sigma; grade III).
Generation of Cytotoxic Cells in an Autologous Theileria
MLC. Animal B641 was immunized against T. parva
(Muguga) by inoculation of sporozoites and treatment with
long-acting oxytetracycline (4). Ninety-five weeks after im-
munization, an autologous Theileria MLC was established
from the animal. PBM were obtained from venous blood
collected into Alsever's solution as described previously (18).
Aliquots of 4 x 106 PBM and 2 x 105 y-irradiated [5000 rads
(1 rad = 0.01 gray) from a .37Cs source] autologous T. parva
(Muguga)-infected stimulator cells were added to the wells of
24-well cluster plates (Costar, Cambridge, MA) in a total
volume of 2 ml of culture medium. After 7 days, cells were
harvested from the wells, and viable cells were separated on
Ficoll-Paque (Pharmacia) and restimulated with irradiated
autologous parasitized cells as in the primary culture. The
cells were similarly stimulated with irradiated parasitized
autologous cells for a third, fourth, and fifth time at weekly
intervals, except that at the third stimulation, 2 x 106
responder cells and 2 x 106 y-irradiated autologous PBM as
filler cells were added per well and at the fourth and fifth
stimulations 1 x 106 responder cells and 3 x 106 filler cells
were added per well.
Cloning and Screening of Cytotoxic Cells. Clones were
derived from the autologous Theileria MLC 7 days after the
fifth in vitro stimulation. To increase the frequency of clones
restricted by class I MHC molecules, the parent cell popu-
lation was depleted of BoT4' lymphocytes by complement-
mediated lysis with mAb IL-A12 as described previously
(19). The cells were resuspended at 106 per ml in culture
medium supplemented with 10% TCGF and maintained at
390C overnight prior to cloning. Cells were cloned by limiting
dilution in 96-well round-bottom culture plates (Costar): cells
were distributed at 0.3 and 1 cell per well with 1 x 103
y-irradiated autologous infected cells as stimulators and 2 x
1 y-irradiated autologous PBM as fillers, in a final volume
of 200 /il of culture medium supplemented with 20% TCGF
containing 0.1 M methyl a-D-mannoside. After 2 weeks, wells
with cell growth were identified. Rapidly growing clones
were split into six round-bottom wells and restimulated as for
initial cloning, while slow-growing clones were restimulated
in the original well to be split and propagated later.
One week after splitting, clones were tested for cytotoxic
activity and positive clones were expanded further in 96-well
round-bottom plates. After 1 week, cells were transferred to
24-well cluster plates: 2 x 105 effector cells and 2 x 106
irradiated stimulator cells were added per well in 2 ml of
culture medium containing 20%o TCGF. The cytotoxic cells
were subsequently maintained in 24-well cluster plates by
similar stimulations every 2 weeks. Cell numbers increased 5-
to 50-fold over a period of 2 weeks.
Cytotoxicity Assays. An indium-111 ("1'In) release assay
(20) was used for initial screening of clones for cytotoxicity.
Target cells, obtained from cultures in exponential growth
phase, were resuspended in cytotoxicity medium and labeled
with [1lIn]indium oxine (Amersham International, Amer-
sham, U.K.; code IN.1SP). Aliquots (50 Al) containing 106
cells were incubated with 5 uCi (1 Ci = 37 GBq) of
[1lIn]indium oxine at 390C for 15 min. The labeled cells were
washed six times in 6 ml of cytotoxicity medium. Effectors
from 1 well of a 96-well round-bottom plate (estimated to
contain 5-10 x 103 cells) were screened on two targets,
namely autologous uninfected lymphoblasts and autologous
cells infected with T. parva (Muguga). The effectors were
mixed with 5 x 103 "'In-labeled target cells in V-bottom wells
of 96-well plates (Flow Laboratories), pelleted by centrifu-
gation (7 min at 160 x g), and incubated for 4 hr at 390C in a
humidified atmosphere of 5% CO2 in air. The cytotoxicity
medium consisted of RPMI-1640 medium with 10% fetal
bovine serum.
The cytotoxic activity of established cloned cells was
measured in a 4-hr 51Cr release assay using 5 x 104 target cells
per well (18). Percent cytotoxic release of51Cr or 111in, herein
referred to as percent cytotoxicity, was calculated as 100 x
(test release - spontaneous release)/(freeze-thaw release -
spontaneous release).
Blocking Assay. Several mAbs and bovine alloantisera
were tested for their capacity to block cytotoxicity by
interaction with either the target cells or the effector cells.
For blocking, 100 ,ul of antibody was added either to 50 ,ul of
51Cr-labeled target cells or to 100 ul of effector cells in the
wells of 96-well flat-bottom culture plates (Costar) and
incubated for 1 hr at 23TC. Aliquots, 100 .il of effector cells
or 50 .ul of target cells, were then added, respectively, to the
preincubated targets or effectors and plates were incubated
for 4 hr at 390C.
mAbs and alloantisera were used at a final dilution that
gave 10 to 100 times saturating levels of binding as assessed
by indirect immunofluorescence analysis.
Alloantisera and mAbs. Alloantiserum KNA104 defines the
KN104 specificity, which is expressed in some cattle with the
BoLA-A wlO specificity and some without the wlO specific-
ity. Alloantiserum KNA109 recognizes another BoLA-A
specificity not present on KN104+ animals. mAb IL-A4
(IgM) recognizes a polymorphic MHC determinant restricted
to animals expressing the KN104 specificity. mAb w6/32
(IgG2a) defines a monomorphic determinant on human HLA-
A, -B, and -C molecules (21) and crossreacts in a nonpoly-
morphic fashion with bovine class I MHC molecules (22).
mAb B1.1G6 (IgG2a) reacts with human and bovine P2-
microglobulin (23, 24). mAb BT3/8 (IgG2a) recognizes a cell
surface molecule that is expressed on all cell lines infected
with Theileria and on some normal bovine leukocytes (25).
mAbs IL-A12 (IgG2a) and IL-A17 (IgGl) identify two
distinct subpopulations of T lymphocytes in cattle; these
have been termed BoT4' (38) and BoT8' (39), respectively,
because of their similarities to human T-cell populations
defined by CD4 and CD8.
Immunoprecipitation. Con A-stimulated lymphoblasts
were surface-labeled with Nal25I by the lactoperoxidase
technique (26). Solubilization oflabeled cells, immunoprecip-
itation with Staphylococcus protein A-Sepharose, and sodi-
um dodecyl sulfate/polyacrylamide gel electrophoresis ofthe
precipitated samples were carried out as described previous-
ly (25), with minor modifications. Immunoprecipitation was
performed at pH 7.5, except in the case ofmAb IL-A4, which
was used at pH 8.5. Molecules reacting with a particular
antibody were removed from the lysate prior to precipitation
with a second antibody by several rounds of precipitation
until the radioactivity in the pellet was equal to that in
negative controls.
RESULTS
Propagation and Cloning of Theilera-Specific Cytotoxic
Cells. No cytotoxic activity was detected in PBM from B641
at the time of initiation of the autologous Theileria MLC.
However, after five stimulations in vitro with autologous
irradiated parasitized cells, 95% cytotoxicity was observed at
an effector-to-target ratio of 15:1. Killing was restricted to the
autologous infected target and those allogenic infected tar-
gets that were matched for one or other BoLA-A product.
There was no killing of uninfected targets. Qn cloning of this
population, after depletion of BoT4' cells, cell growth was
detected in 36 out of 768 wells at 0.3 cell per well, and 46 out
of 380 wells at 1 cell per well. Cells in 27 wells exhibited
cytotoxic activity. Three clones, T15.8, T15.114, and
T15.132, restricted to autologous infected cells, were expand-
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FIG. 1. Blocking of target cell lysis in the cytotoxicity assay by
preincubation of target cells with antibodies. Cytotoxic T-cell clone
T15.114 was used as an effector against a target cell line infected with
T. parva (Muguga) from animal C603. Effectors were harvested 2
weeks (a) or 1 week (b) after last stimulation. The following
antibodies were used in a: 9, none; *, KNA104; o, KNA109. In b:
0, none; A, IL-A4; o, BT3/8; v, w6/32; o, Bl.lG6.
ed for further characterization. These clones exhibited max-
imal killing potency around 7 days after stimulation, giving
100% cytotoxicity at an effector-to-target ratio of 0.25:1 to
0.5:1 (Fig. lb). When cells were harvested more than 1 week
Table 1. MHI-C restriction of three Theileria-specific cytotoxic
clones from animal B641, tested on a panel of bovine cells
infected with T. parva (Muguga)
Target
Class I MHC
T. parva phenotype detected
(Muouga)- By mAb
infected By allo- IL-A4 or % cytotoxicity by clone*
cell line antiserum KNA104 T15.8 T15.114 T15.132
B641 w10/KN18 + 87 81 84
C167 w10/w4 + 102 96 99
C234 wlO/w6 + 87 87 79
C447 wlO/w7 + 111 113 122
ND2 wlO/w20 + 101 101 99
B166 w1O/w4 + 117 115 111
C603 wlO/- + 94 95 96
B732 wlO/w6 - 2 3 1
C315 wlO/w6 - 1 2 1
C538 wlO/KN22 - 0 0 0
S823 wlO/w13 - 1 0 0
D96 wlO/w6 - 0 0 0
C17 w10/w7 - 0 0 0
K240 w7/- + 97 94 101
K96 w8/- + 63 62 62
K104 wi/- + 116 109 108
B171 KN18/w7 - 3 3 2
C481 KN18/- - 3 2 3
C631 KN18/- - 2 2 1
C428 KN18/- - 2 1 2
B353 w20/- - 2 2 2
C165 w6/w7 - 2 0 0
C401 w6/w4 - 2 1 3
S829 w13/w16 - 0 0 1
*Results are presented for an effector-to-target ratio of 1:1.
after stimulation, higher effector-to-target ratios were re-
quired to obtain maximum cytotoxicity (Fig. la). The clones
have been maintained in culture for 8 months without loss of
cytotoxic capacity or specificity.
MHC Restriction of Theileria-Specific Cytotoxic Clones.
Cytotoxic activity of the three clones was tested on several
occasions on a total of 32 T. parva (Muguga)-infected cell
lines from 24 animals. The three clones had similar MHC
restriction patterns. Only autologous targets and allogenic
targets from animals expressing the KN104 specificity were
killed (Table 1). The latter group consisted of some animals
expressing the wlO specificity and some animals expressing
neither the w10 nor the KN18 specificity.
Parasite Restriction and Strain Specificity of the Cytotoxic
Clones. The three cytotoxic clones did not kill uninfected
autologous and allogenic targets from nine different animals
expressing the KN104 specificity. They killed target cells
infected with T. parva (Muguga) but did not kill targets
infected with T. parva (Marikebuni). This was based on
results using target cells originating from four different
KN104+ animals. The targets consisted of bulk cultures and
their derivative clones infected with either of the two parasite
stocks, and a precloned T-cell population infected with either
of the two parasite stocks (Table 2, Fig. 2).
The Restricting MHC Molecule for the Theileria-Specific
Cytotoxic Clones. Immunoprecipitation studies on cells of
B641 with alloantisera KNA104 and anti-wlO, and mAbs
IL-A4 and w6/32 confirmed that these antibodies precipitat-
ed class I MHC molecules-i.e., two polypeptides, 45 and 12
kDa (Fig. 3). Sequential immunoprecipitation of lysates of
B641 cells with alloantiserum KNA104 and an anti-wlO
alloantiserum (Fig. 3) showed that alloantiserum KNA104
Table 2. Parasite restriction and strain specificity of three
cytotoxic T-cell clones from animal B641
Target
Class I MHC pheno-
type detected
By mAb
By allo- IL-A4 or % cytotoxicity by clonet
Cell line* antiserum KNA104 T15.8 T15.114 T15.132
B641 TpM wlO/KN18 + 87 81 84
B641 TpM 1 73 65 65
B641 TpM 2 75 68 67
B641 TpA 17 7 6 9
B641 TpA 18 12 8 8
B641 blasts 0 0 0
C234 TpM wlO/w6 + 87 87 89
C234 TpA 12 10 6 4
C234 TpA 13 8 8 7
C234 blasts 1 0 1
C167 TpM wlO/w4 + 102 96 99
C167 TpA 2 3 3
C167 blasts 0 0 0
T16.13 TpM wlO/w7 + 106 92 97
T16.13 TpA 3 3 4
T16.13 0 0 0
*Cell lines are identified by the number of the donor animal or T-cell
line, followed by the parasite strain identification if infected: TpM
= Muguga, TpA = Marikebuni. T. parva-infected cell lines that
have been cloned are identified by a number after the parasite strain.
Blasts originated from cultures of Con A-stimulated blasts main-
tained in 20%o TCGF. T16.13 is a cloned uninfected T-cell line from
animal C447.
tResults are presented for an effector-to-target ratio of 1:1.
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FIG. 2. Parasite restriction and strain specificity of cytotoxic
T-cell clone T15.132. Effectors were harvested 9 days after last
stimulation. Cytotoxicity was analyzed on infected and uninfected
targets originating from bulk cell lines of animal C167 (a) or from
precloned T-cell line T16.13 of animal C447 (b): v, uninfected cells;
*, cells infected with T. parva (Muguga); *, cells infected with T.
parva (Marikebuni).
and anti-wlO alloantiserum recognized determinants on the
same class I molecule from B641 cells. Similar results were
obtained by using mAb IL-A4 followed by anti-W10 al-
loantiserum (not shown).
Blocking of Cytotoxicity by MHC-Defining mAbs and Al-
loantisera. To confirm the involvement of class I MHC
molecules in restricting the cytotoxicity, experiments were
conducted to test whether or not lysis could be blocked by
preincubating the targets with antibodies recognizing the
restricting class I MHC molecule. T. parva (Muguga)-
infected cells from animal C603 carrying the wlO and KN104
specificities were used as target cells. Preincubation of C603
target cells with mAb IL-A4, alloantiserum KNA104, or mAb
w6/32 reduced cytotoxicity by more than 90% (Fig. 1). Two
other mAbs recognizing the target cells-namely, mAb
BT3/8, which reacts with a non-MHC molecule (25), and
mAb B1.1G6, which recognizes bovine /32-microglobulin
(24)-did not block the cytolysis (Fig. 1). Alloantiserum
KNA109, which does not recognize the target cell, did not
influence the killing (Fig. 1).
Cell Surface Phenotype of the Theileria-Speciflic Cytotoxic
Clones. The three cytotoxic clones were BoT4-, BoT8+.
When these effectors were incubated with mAbs IL-A12 or
IL-A17 before inclusion in cytotoxicity assays, IL-A17 in-
hibited killing by 20-30%, whereas IL-A12 had no effect.
A B C D E
45- w
31-
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FIG. 3. Immunoprecipitation of Nonidet P-40 detergent extracts
of cell surface '251-labeled Con A-stimulated blasts of animal B641.
Sequential immunoprecipitation was performed with KNA104 (lane
A), followed by an anti-wlO alloantiserum (lane B). Single im-
munoprecipitations were performed with anti-wlO alloantiserum
(lane C), mAb IL-A4 (lane D), and mAb w6/32 (lane E).
DISCUSSION
Three Theileria-specific cytotoxic clones were isolated from
a population of PBM that had been stimulated five times in
vitro with autologous T. parva (Muguga)-infected cells.
These clones were parasite strain-specific and restricted by a
class I MHC determinant.
The results of the present study extend previous observa-
tions on the immune responses of cattle to T. parva (6) and
the related parasite Theileria annulata (27), which indicated
that cytotoxic cells specific for parasitized lymphoblasts
were probably restricted by class I MHC antigens. Cytotoxic
activity of the three clones was restricted to targets bearing
the KN104 specificity, which, in animal B641, is expressed
on the class I MHC A locus-encoded molecule bearing the
w10 specificity. This was confirmed by the ability of al-
loantiserum KNA104 and mAb IL-A4 to block lysis of the
target cells. However, mAb w6/32, which reacts with a
monomorphic determinant on the MHC molecule, was equal-
ly efficient at blocking cytotoxicity. Similar blocking of
cytotoxicity by w6/32 has been reported with human
cytotoxic cells specific for targets infected with influenza
virus or Epstein-Barr virus (28-31). In these studies, it was
suggested that blocking was due to steric hindrance by the
mAb, to antibody-induced conformational alteration of the
MHC molecule (28, 29), or possibly to interference in the
association ofthe virus antigen with the MHC molecules (29).
Similar mechanisms may account for blocking with w6/32 in
the studies reported here.
The demonstration that the three Theileria-specific cytotoxic
clones have the BoT8', BoT4- phenotype further illustrates the
similar functional properties of bovine BoT8+ cells with human
CD8+ lymphocytes (31). The low level of blocking of
cytotoxicity by mAb IL-A17 in the present study may relate to
the relatively high avidity of the idiotypic receptor of the
cytotoxic T-cell clones for the target antigen, as has been
suggested previously for blocking with mAb to Lyt-2,3 in mice
(32), or to the epitope recognized by mAb IL-A17 being distant
from the functional site on the BoT8 molecule.
Previous observations that bulk populations of Theileria-
specific cytotoxic cells generated in vivo are biased in their
killing towards targets infected with the parasite stock used
for immunization (9) have been open to the criticism that
target cell lines may vary in their inherent susceptibility to
lysis, possibly as a result of infection of different cell types by
the parasites. However, we have clearly demonstrated strain
specificity ofcloned effectors by using as targets a population
of precloned T cells infected with two different stocks of the
parasite. Cross-immunity trials have shown that T. parva
(Marikebuni)-immune animals resist challenge with T. parva
(Muguga), whereas fatal breakthrough infections occur in T.
parva (Muguga)-immune animals when challenged with T.
parva (Marikebuni) (5). The strain specificity of cytotoxic T-
cell clones generated from an animal immunized with T.
parva (Muguga), if representative of the response in vivo,
may account for the failure to protect against challenge with
T. parva (Marikebuni). Nevertheless, in bulk cultures of
cytotoxic T cells derived from T. parva (Muguga)-immune
animals by repeated stimulation of PBM in vitro, there is
some killing of targets infected with T. parva (Marikebuni),
suggesting that crossreactive populations of cytotoxic cells
may exist (unpublished data). Variability between individual
animals in the degree of protection conferred against chal-
lenge with T. parva (Marikebuni) by immunization with T.
parva (Muguga) (5) may be due to the extent to which
crossreactive effector cells are induced. By the same logic,
one might expect cytotoxic cells generated against T. parva
(Marikebuni) to be predominantly crossreactive. Generation
of further cytotoxic T-cell clones against different parasite
strains will be required to answer these questions. The
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information obtained to date indicates some parallels with
responses to influenza type A viruses in humans, for which
virus subtype-specific and crossreactive cytotoxic T-cell
clones have been demonstrated (33).
To our knowledge MHC-restricted cytotoxic T-cell re-
sponses to protozoan parasites have not been reported for
parasites other than Theileria species (6, 27). Helper/inducer
T-cell responses have been demonstrated in mice infected
with Plasmodium and Leishmania parasites and have been
shown to participate in the generation of protective responses
(34, 35). In the case ofLeishmania tropica, these T cells have
also been cloned (35). However, generation of such respons-
es appeared to require the presence of mononuclear
phagocytic cells to process and present the parasite antigen,
whereas Theileria-specific clones responded to parasite-
induced changes on the membrane of the infected cell itself.
Cattle immunized against T. parva do not produce anti-
bodies that react with the surface of parasitized cells (36).
Furthermore, attempts to identify parasite products on the
cell surface by using biochemical techniques and mAbs have
so far been unsuccessful (6). Thus, at present, it is not
possible to say whether the target antigen is of host or
parasite origin, although the detection of parasite strain
specificity on the part of T cells would favor the latter
possibility. Similar problems in identifying the surface anti-
gen recognized by the cytotoxic cells have been encountered
with Epstein-Barr virus-infected and influenza virus-infected
cells from humans (33, 37). In the latter, transfection of viral
genes was required to provide definitive information on the
virus molecules responsible for membrane changes recog-
nized by the cytotoxic cell (33). Such an approach might be
possible with Theileria-specific cytotoxic cells, should it
become possible to identify the parasite gene(s) responsible
for changes on the infected cell membrane, either directly or
with mAbs recognizing the gene product.
In conclusion, the results of this study have demonstrated
that cytotoxic T cells, which are restricted by class I MHC
molecules and are parasite strain-specific, can be propagated
and cloned in vitro from immune cattle. Findings on the
specificity of these effectors, taken together with previous
observations on cross-protection with different stocks of T.
parva, suggest that these cytotoxic cells are important in
mediating immunity to the parasite, and thus they may be of
use, in conjunction with biochemical and molecular biolog-
ical techniques, to identify antigens that could be used for
immunization.
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